[
  {
    "ts": null,
    "headline": "Globus Medical: Obtaining My Backing Again",
    "summary": "Globus Medical shares have reset after a soft Q1 and Nevro acquisition, making valuations more attractive despite near-term dilution. Read the full GMED stock analysis.",
    "url": "https://finnhub.io/api/news?id=71099eb95bbde3c97e081ab43a0cb4778dea5ba855839f3e96a3dd49ebadb029",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751544630,
      "headline": "Globus Medical: Obtaining My Backing Again",
      "id": 135738284,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1860536835/image_1860536835.jpg?io=getty-c-w1536",
      "related": "SYK",
      "source": "SeekingAlpha",
      "summary": "Globus Medical shares have reset after a soft Q1 and Nevro acquisition, making valuations more attractive despite near-term dilution. Read the full GMED stock analysis.",
      "url": "https://finnhub.io/api/news?id=71099eb95bbde3c97e081ab43a0cb4778dea5ba855839f3e96a3dd49ebadb029"
    }
  }
]